 | • レポートコード：GIR-2104Z05929 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、フルオキセチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フルオキセチンの種類別市場規模（錠剤、カプセル、経口液剤）、用途別市場規模（うつ病、強迫性障害、パニック障害、神経性過食症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・フルオキセチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Teva、Sun Pharmaceutical、Sandoz、Mylan、Wockhardt、Dr.Reddy's Laboratories、Pharmaceutical Associates Inc.、Lannett Company、Aurobindo Pharma、Alembic Pharmaceuticals、Alvogen、Torrent Pharmaceuticals、Suzhou YUSHI Pharmaceutical、Changzhou Siyao Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、カプセル、経口液剤 ・用途別分析2016年-2026年：うつ病、強迫性障害、パニック障害、神経性過食症、その他 ・フルオキセチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・フルオキセチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・フルオキセチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フルオキセチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・フルオキセチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fluoxetine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Fluoxetine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Fluoxetine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Fluoxetine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsules
Oral Solution
Market segment by Application can be divided into
Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
The key market players for global Fluoxetine market are listed below:
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy’s Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Fluoxetine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fluoxetine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Oral Solution
1.3 Market Analysis by Application
1.3.1 Overview: Global Fluoxetine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Depression
1.3.3 Obsessive–Compulsive Disorder
1.3.4 Panic Disorder
1.3.5 Bulimia Nervosa
1.3.6 Others
1.4 Global Fluoxetine Market Size & Forecast
1.4.1 Global Fluoxetine Sales in Value (2016-2026))
1.4.2 Global Fluoxetine Sales in Volume (2016-2026)
1.4.3 Global Fluoxetine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Fluoxetine Production Capacity Analysis
1.5.1 Global Fluoxetine Total Production Capacity (2016-2026)
1.5.2 Global Fluoxetine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fluoxetine Market Drivers
1.6.2 Fluoxetine Market Restraints
1.6.3 Fluoxetine Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Fluoxetine Product and Services
2.1.4 Teva Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sun Pharmaceutical
2.2.1 Sun Pharmaceutical Details
2.2.2 Sun Pharmaceutical Major Business
2.2.3 Sun Pharmaceutical Fluoxetine Product and Services
2.2.4 Sun Pharmaceutical Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Fluoxetine Product and Services
2.3.4 Sandoz Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Fluoxetine Product and Services
2.4.4 Mylan Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Wockhardt
2.5.1 Wockhardt Details
2.5.2 Wockhardt Major Business
2.5.3 Wockhardt Fluoxetine Product and Services
2.5.4 Wockhardt Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Dr.Reddy’s Laboratories
2.6.1 Dr.Reddy’s Laboratories Details
2.6.2 Dr.Reddy’s Laboratories Major Business
2.6.3 Dr.Reddy’s Laboratories Fluoxetine Product and Services
2.6.4 Dr.Reddy’s Laboratories Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pharmaceutical Associates Inc.
2.7.1 Pharmaceutical Associates Inc. Details
2.7.2 Pharmaceutical Associates Inc. Major Business
2.7.3 Pharmaceutical Associates Inc. Fluoxetine Product and Services
2.7.4 Pharmaceutical Associates Inc. Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lannett Company
2.8.1 Lannett Company Details
2.8.2 Lannett Company Major Business
2.8.3 Lannett Company Fluoxetine Product and Services
2.8.4 Lannett Company Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Fluoxetine Product and Services
2.9.4 Aurobindo Pharma Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Alembic Pharmaceuticals
2.10.1 Alembic Pharmaceuticals Details
2.10.2 Alembic Pharmaceuticals Major Business
2.10.3 Alembic Pharmaceuticals Fluoxetine Product and Services
2.10.4 Alembic Pharmaceuticals Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Alvogen
2.11.1 Alvogen Details
2.11.2 Alvogen Major Business
2.11.3 Alvogen Fluoxetine Product and Services
2.11.4 Alvogen Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Torrent Pharmaceuticals
2.12.1 Torrent Pharmaceuticals Details
2.12.2 Torrent Pharmaceuticals Major Business
2.12.3 Torrent Pharmaceuticals Fluoxetine Product and Services
2.12.4 Torrent Pharmaceuticals Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Suzhou YUSHI Pharmaceutical
2.13.1 Suzhou YUSHI Pharmaceutical Details
2.13.2 Suzhou YUSHI Pharmaceutical Major Business
2.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Product and Services
2.13.4 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Changzhou Siyao Pharmaceutical
2.14.1 Changzhou Siyao Pharmaceutical Details
2.14.2 Changzhou Siyao Pharmaceutical Major Business
2.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Product and Services
2.14.4 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Fluoxetine Sales by Manufacturer
3.1 Global Fluoxetine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Fluoxetine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Fluoxetine
3.4 Market Concentration Rate
3.4.1 Top 3 Fluoxetine Manufacturer Market Share
3.4.2 Top 6 Fluoxetine Manufacturer Market Share
3.5 Global Fluoxetine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Fluoxetine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fluoxetine Market Size by Region
4.1.1 Global Fluoxetine Sales in Volume by Region (2016-2026)
4.1.2 Global Fluoxetine Revenue by Region (2016-2026)
4.2 North America Fluoxetine Revenue (2016-2026)
4.3 Europe Fluoxetine Revenue (2016-2026)
4.4 Asia-Pacific Fluoxetine Revenue (2016-2026)
4.5 South America Fluoxetine Revenue (2016-2026)
4.6 Middle East and Africa Fluoxetine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Fluoxetine Sales in Volume by Type (2016-2026)
5.2 Global Fluoxetine Revenue by Type (2016-2026)
5.3 Global Fluoxetine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Fluoxetine Sales in Volume by Application (2016-2026)
6.2 Global Fluoxetine Revenue by Application (2016-2026)
6.3 Global Fluoxetine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Fluoxetine Sales by Type (2016-2026)
7.2 North America Fluoxetine Sales by Application (2016-2026)
7.3 North America Fluoxetine Market Size by Country
7.3.1 North America Fluoxetine Sales in Volume by Country (2016-2026)
7.3.2 North America Fluoxetine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Fluoxetine Sales by Type (2016-2026)
8.2 Europe Fluoxetine Sales by Application (2016-2026)
8.3 Europe Fluoxetine Market Size by Country
8.3.1 Europe Fluoxetine Sales in Volume by Country (2016-2026)
8.3.2 Europe Fluoxetine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Fluoxetine Sales by Type (2016-2026)
9.2 Asia-Pacific Fluoxetine Sales by Application (2016-2026)
9.3 Asia-Pacific Fluoxetine Market Size by Region
9.3.1 Asia-Pacific Fluoxetine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Fluoxetine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Fluoxetine Sales by Type (2016-2026)
10.2 South America Fluoxetine Sales by Application (2016-2026)
10.3 South America Fluoxetine Market Size by Country
10.3.1 South America Fluoxetine Sales in Volume by Country (2016-2026)
10.3.2 South America Fluoxetine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fluoxetine Sales by Type (2016-2026)
11.2 Middle East & Africa Fluoxetine Sales by Application (2016-2026)
11.3 Middle East & Africa Fluoxetine Market Size by Country
11.3.1 Middle East & Africa Fluoxetine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Fluoxetine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Fluoxetine Typical Distributors
12.3 Fluoxetine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Fluoxetine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Fluoxetine Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Fluoxetine Product and Services
Table 6. Teva Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Sun Pharmaceutical Major Business
Table 9. Sun Pharmaceutical Fluoxetine Product and Services
Table 10. Sun Pharmaceutical Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sandoz Basic Information, Manufacturing Base and Competitors
Table 12. Sandoz Major Business
Table 13. Sandoz Fluoxetine Product and Services
Table 14. Sandoz Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Fluoxetine Product and Services
Table 18. Mylan Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 20. Wockhardt Major Business
Table 21. Wockhardt Fluoxetine Product and Services
Table 22. Wockhardt Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dr.Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr.Reddy's Laboratories Major Business
Table 25. Dr.Reddy's Laboratories Fluoxetine Product and Services
Table 26. Dr.Reddy's Laboratories Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pharmaceutical Associates Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Pharmaceutical Associates Inc. Major Business
Table 29. Pharmaceutical Associates Inc. Fluoxetine Product and Services
Table 30. Pharmaceutical Associates Inc. Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lannett Company Basic Information, Manufacturing Base and Competitors
Table 32. Lannett Company Major Business
Table 33. Lannett Company Fluoxetine Product and Services
Table 34. Lannett Company Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Aurobindo Pharma Major Business
Table 37. Aurobindo Pharma Fluoxetine Product and Services
Table 38. Aurobindo Pharma Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Alembic Pharmaceuticals Major Business
Table 41. Alembic Pharmaceuticals Fluoxetine Product and Services
Table 42. Alembic Pharmaceuticals Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Alvogen Basic Information, Manufacturing Base and Competitors
Table 44. Alvogen Major Business
Table 45. Alvogen Fluoxetine Product and Services
Table 46. Alvogen Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Torrent Pharmaceuticals Major Business
Table 49. Torrent Pharmaceuticals Fluoxetine Product and Services
Table 50. Torrent Pharmaceuticals Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Suzhou YUSHI Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Suzhou YUSHI Pharmaceutical Major Business
Table 53. Suzhou YUSHI Pharmaceutical Fluoxetine Product and Services
Table 54. Suzhou YUSHI Pharmaceutical Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Changzhou Siyao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Changzhou Siyao Pharmaceutical Major Business
Table 57. Changzhou Siyao Pharmaceutical Fluoxetine Product and Services
Table 58. Changzhou Siyao Pharmaceutical Fluoxetine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Fluoxetine Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Fluoxetine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Fluoxetine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Fluoxetine Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Fluoxetine Production Site of Key Manufacturer
Table 64. Global Fluoxetine Sales by Region (2016-2021e) & (K Units)
Table 65. Global Fluoxetine Sales by Region (2021-2026) & (K Units)
Table 66. Global Fluoxetine Revenue by Region (2016-2021e) & (USD Million)
Table 67. Global Fluoxetine Revenue by Region (2021-2026) & (USD Million)
Table 68. Global Fluoxetine Sales by Type (2016-2021e) & (K Units)
Table 69. Global Fluoxetine Sales by Type (2021-2026) & (K Units)
Table 70. Global Fluoxetine Revenue by Type (2016-2021e) & (USD Million)
Table 71. Global Fluoxetine Revenue by Type (2021-2026) & (USD Million)
Table 72. Global Fluoxetine Price by Type (2016-2021e) & (USD/Unit)
Table 73. Global Fluoxetine Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Fluoxetine Sales by Application (2016-2021e) & (K Units)
Table 75. Global Fluoxetine Sales by Application (2021-2026) & (K Units)
Table 76. Global Fluoxetine Revenue by Application (2016-2021e) & (USD Million)
Table 77. Global Fluoxetine Revenue by Application (2021-2026) & (USD Million)
Table 78. Global Fluoxetine Price by Application (2016-2021e) & (USD/Unit)
Table 79. Global Fluoxetine Price by Application (2021-2026) & (USD/Unit)
Table 80. North America Fluoxetine Sales by Country (2016-2021e) & (K Units)
Table 81. North America Fluoxetine Sales by Country (2021-2026) & (K Units)
Table 82. North America Fluoxetine Revenue by Country (2016-2021e) & (USD Million)
Table 83. North America Fluoxetine Revenue by Country (2021-2026) & (USD Million)
Table 84. North America Fluoxetine Sales by Type (2016-2021e) & (K Units)
Table 85. North America Fluoxetine Sales by Type (2021-2026) & (K Units)
Table 86. North America Fluoxetine Sales by Application (2016-2021e) & (K Units)
Table 87. North America Fluoxetine Sales by Application (2021-2026) & (K Units)
Table 88. Europe Fluoxetine Sales by Country (2016-2021e) & (K Units)
Table 89. Europe Fluoxetine Sales by Country (2021-2026) & (K Units)
Table 90. Europe Fluoxetine Revenue by Country (2016-2021e) & (USD Million)
Table 91. Europe Fluoxetine Revenue by Country (2021-2026) & (USD Million)
Table 92. Europe Fluoxetine Sales by Type (2016-2021e) & (K Units)
Table 93. Europe Fluoxetine Sales by Type (2021-2026) & (K Units)
Table 94. Europe Fluoxetine Sales by Application (2016-2021e) & (K Units)
Table 95. Europe Fluoxetine Sales by Application (2021-2026) & (K Units)
Table 96. Asia-Pacific Fluoxetine Sales by Region (2016-2021e) & (K Units)
Table 97. Asia-Pacific Fluoxetine Sales by Region (2021-2026) & (K Units)
Table 98. Asia-Pacific Fluoxetine Revenue by Region (2016-2021e) & (USD Million)
Table 99. Asia-Pacific Fluoxetine Revenue by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Fluoxetine Sales by Type (2016-2021e) & (K Units)
Table 101. Asia-Pacific Fluoxetine Sales by Type (2021-2026) & (K Units)
Table 102. Asia-Pacific Fluoxetine Sales by Application (2016-2021e) & (K Units)
Table 103. Asia-Pacific Fluoxetine Sales by Application (2021-2026) & (K Units)
Table 104. South America Fluoxetine Sales by Country (2016-2021e) & (K Units)
Table 105. South America Fluoxetine Sales by Country (2021-2026) & (K Units)
Table 106. South America Fluoxetine Revenue by Country (2016-2021e) & (USD Million)
Table 107. South America Fluoxetine Revenue by Country (2021-2026) & (USD Million)
Table 108. South America Fluoxetine Sales by Type (2016-2021e) & (K Units)
Table 109. South America Fluoxetine Sales by Type (2021-2026) & (K Units)
Table 110. South America Fluoxetine Sales by Application (2016-2021e) & (K Units)
Table 111. South America Fluoxetine Sales by Application (2021-2026) & (K Units)
Table 112. Middle East & Africa Fluoxetine Sales by Country (2016-2021e) & (K Units)
Table 113. Middle East & Africa Fluoxetine Sales by Country (2021-2026) & (K Units)
Table 114. Middle East & Africa Fluoxetine Revenue by Country (2016-2021e) & (USD Million)
Table 115. Middle East & Africa Fluoxetine Revenue by Country (2021-2026) & (USD Million)
Table 116. Middle East & Africa Fluoxetine Sales by Type (2016-2021e) & (K Units)
Table 117. Middle East & Africa Fluoxetine Sales by Type (2021-2026) & (K Units)
Table 118. Middle East & Africa Fluoxetine Sales by Application (2016-2021e) & (K Units)
Table 119. Middle East & Africa Fluoxetine Sales by Application (2021-2026) & (K Units)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Fluoxetine Typical Distributors
Table 123. Fluoxetine Typical Customers
List of Figures
Figure 1. Fluoxetine Picture
Figure 2. Global Fluoxetine Sales Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Oral Solution
Figure 6. Global Fluoxetine Sales Market Share by Application in 2020
Figure 7. Depression
Figure 8. Obsessive–Compulsive Disorder
Figure 9. Panic Disorder
Figure 10. Bulimia Nervosa
Figure 11. Others
Figure 12. Global Fluoxetine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Fluoxetine Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Fluoxetine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Fluoxetine Sales (2016-2026) & (K Units)
Figure 34. Global Fluoxetine Production Capacity (2016-2026) & (K Units)
Figure 35. Global Fluoxetine Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Fluoxetine Market Drivers
Figure 37. Fluoxetine Market Restraints
Figure 38. Fluoxetine Market Trends
Figure 39. Global Fluoxetine Sales Market Share by Manufacturer in 2020
Figure 40. Global Fluoxetine Revenue Market Share by Manufacturer in 2020
Figure 41. Fluoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Fluoxetine Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Fluoxetine Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Fluoxetine Sales Market Share by Region (2016-2026)
Figure 45. Global Fluoxetine Revenue Market Share by Region (2016-2026)
Figure 46. North America Fluoxetine Revenue (2016-2026) & (USD Million)
Figure 47. Europe Fluoxetine Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Fluoxetine Revenue (2016-2026) & (USD Million)
Figure 49. South America Fluoxetine Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Fluoxetine Revenue (2016-2026) & (USD Million)
Figure 51. Global Fluoxetine Sales Market Share by Type (2016-2026)
Figure 52. Global Fluoxetine Revenue Market Share by Type (2016-2026)
Figure 53. Global Fluoxetine Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Fluoxetine Sales Market Share by Application (2016-2026)
Figure 55. Global Fluoxetine Revenue Market Share by Application (2016-2026)
Figure 56. Global Fluoxetine Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Fluoxetine Sales Market Share by Country (2016-2026)
Figure 58. North America Fluoxetine Revenue Market Share by Country (2016-2026)
Figure 59. North America Fluoxetine Sales Market Share by Type (2016-2026)
Figure 60. North America Fluoxetine Sales Market Share by Application (2016-2026)
Figure 61. Europe Fluoxetine Sales Market Share by Country (2016-2026)
Figure 62. Europe Fluoxetine Revenue Market Share by Country (2016-2026)
Figure 63. Europe Fluoxetine Sales Market Share by Type (2016-2026)
Figure 64. Europe Fluoxetine Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Fluoxetine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Fluoxetine Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Fluoxetine Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Fluoxetine Sales Market Share by Application (2016-2026)
Figure 69. South America Fluoxetine Sales Market Share by Country (2016-2026)
Figure 70. South America Fluoxetine Revenue Market Share by Country (2016-2026)
Figure 71. South America Fluoxetine Sales Market Share by Type (2016-2026)
Figure 72. South America Fluoxetine Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Fluoxetine Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Fluoxetine Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Fluoxetine Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Fluoxetine Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の強迫性障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Obsessive-Compulsive Disorder Treatment Market The global Obsessive-Compulsive Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の全般性不安障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global General Anxiety Disorder Therapeutics Market The global General Anxiety Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の自閉症スペクトラム障害市場規模・現状・予測（2021年-2027年） Autism spectrum disorder (ASD) is a neurological and developmental disorder that begins early in childhood and lasts throughout a person's life. It affects how a person acts and interacts with others, communicates, and learns. It includes what used to be known as Asperger syndrome and pervasive deve…
- 世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
- 世界の脂質障害治療市場規模・現状・予測（2021年-2027年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…